Techcyte: Advancing Pathology Through Digital Transformation
Founded in 2013, Techcyte is a global leader in AI-based digital pathology, serving clinical,
anatomic, veterinary, and environmental laboratories across more than 40 countries. At
the heart of its innovation is Techcyte Fusion™, a single platform that leverages artificial
intelligence to digitize and optimize the entire diagnostic workflow.
With solutions supporting a wide range of pathology sub specialities—including histology
parasitology, frozen section, bacteriology, and cervical cytology—Techcyte addresses key
challenges facing laboratories today, such as workforce shortages, inter-operator
variability, and the demand for faster, more scalable diagnostics. Fusion is designed for
interoperability, integrating seamlessly with existing laboratory information systems (LIS) to
streamline case management report signout.
Techcyte is actively engaged in advancing AI-assisted digital pathology through clinical
validation, academic partnerships, and global collaborations. Notably, the company has
collaborated with leading institutions to co-develop algorithms that are now used in
real-world laboratory settings. Techcyte’s CE-marked solutions are deployed in Europe, and
the company is pursuing FDA clearance for U.S. applications.
Techcyte also supports a variety of scanner vendors to support both low- and
high-throughput laboratories. Its proprietary technologies, including patented imaging
enhancements for sparse samples, ensure quality digitization across various specimen
types.
Through a robust network of global distribution partners and ongoing product innovation,
Techcyte is helping laboratories modernize operations and prepare for the next generation
of pathology.
For more information, visit www.techcyte.com.
